Cargando…
Exosomes and mimics as novel delivery platform for cancer therapy
Exosomes are nano-sized biological extracellular vesicles transmitting information between cells and constituting a new intercellular communication mode. Exosomes have many advantages as an ideal drug delivery nanocarrier, including good biocompatibility, permeability, low toxicity, and low immunoge...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602403/ https://www.ncbi.nlm.nih.gov/pubmed/36313380 http://dx.doi.org/10.3389/fphar.2022.1001417 |
_version_ | 1784817308269543424 |
---|---|
author | Yang, Fuxu Wang, Mingyue Guan, Xingang |
author_facet | Yang, Fuxu Wang, Mingyue Guan, Xingang |
author_sort | Yang, Fuxu |
collection | PubMed |
description | Exosomes are nano-sized biological extracellular vesicles transmitting information between cells and constituting a new intercellular communication mode. Exosomes have many advantages as an ideal drug delivery nanocarrier, including good biocompatibility, permeability, low toxicity, and low immunogenicity. Recently, exosomes have been used to deliver chemotherapeutic agents, natural drugs, nucleic acid drugs, and other antitumor drugs to treat many types of tumors. Due to the limited production of exosomes, synthetic exosome-mimics have been developed as an ideal platform for drug delivery. This review summarizes recent advances in the application of exosomes and exosome-mimics delivering therapeutic drugs in treating cancers. |
format | Online Article Text |
id | pubmed-9602403 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96024032022-10-27 Exosomes and mimics as novel delivery platform for cancer therapy Yang, Fuxu Wang, Mingyue Guan, Xingang Front Pharmacol Pharmacology Exosomes are nano-sized biological extracellular vesicles transmitting information between cells and constituting a new intercellular communication mode. Exosomes have many advantages as an ideal drug delivery nanocarrier, including good biocompatibility, permeability, low toxicity, and low immunogenicity. Recently, exosomes have been used to deliver chemotherapeutic agents, natural drugs, nucleic acid drugs, and other antitumor drugs to treat many types of tumors. Due to the limited production of exosomes, synthetic exosome-mimics have been developed as an ideal platform for drug delivery. This review summarizes recent advances in the application of exosomes and exosome-mimics delivering therapeutic drugs in treating cancers. Frontiers Media S.A. 2022-10-12 /pmc/articles/PMC9602403/ /pubmed/36313380 http://dx.doi.org/10.3389/fphar.2022.1001417 Text en Copyright © 2022 Yang, Wang and Guan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Yang, Fuxu Wang, Mingyue Guan, Xingang Exosomes and mimics as novel delivery platform for cancer therapy |
title | Exosomes and mimics as novel delivery platform for cancer therapy |
title_full | Exosomes and mimics as novel delivery platform for cancer therapy |
title_fullStr | Exosomes and mimics as novel delivery platform for cancer therapy |
title_full_unstemmed | Exosomes and mimics as novel delivery platform for cancer therapy |
title_short | Exosomes and mimics as novel delivery platform for cancer therapy |
title_sort | exosomes and mimics as novel delivery platform for cancer therapy |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602403/ https://www.ncbi.nlm.nih.gov/pubmed/36313380 http://dx.doi.org/10.3389/fphar.2022.1001417 |
work_keys_str_mv | AT yangfuxu exosomesandmimicsasnoveldeliveryplatformforcancertherapy AT wangmingyue exosomesandmimicsasnoveldeliveryplatformforcancertherapy AT guanxingang exosomesandmimicsasnoveldeliveryplatformforcancertherapy |